DSD-T102

Congenital adrenal hyperplasia (CAH) · DSD-T102

DSD-T102 · Congenital adrenal hyperplasia (CAH) · 2018 · Automated translation

Phenotypes HPO:0000771, Gynecomastia (HP:0000771)

Mosaic 45,X/47,XXX Turner syndrome with nonclassic 21-hydroxylase deficiency caused by a CYP21A2 variant.

Case fields and evidence

Category

Congenital adrenal hyperplasia (CAH)

Age

6 years 7 months (last follow-up); pubarche noted at 5 years 8 months.

Phenotypes

Gynecomastia (HP:0000771)

Diagnosis

Mosaic 45,X/47,XXX Turner syndrome with nonclassic 21-hydroxylase deficiency caused by a CYP21A2 variant.

Follow-up

At follow-up at 6 years 7 months, height 121.3 cm (0.51 SD), weight 25.3 kg (1.03 SD), with growth acceleration; continued monitoring of growth and CAH control.

General phenotype

General condition good; low posterior hairline, micrognathia; mild Turner stigmata, no short stature; recurrent otitis media; echocardiography normal.

Imaging

Renal and pelvic ultrasound showed normal kidneys without malformation, uterus 2.3×0.7×1.1 cm, bilateral ovaries 1.2×0.6 cm.

Laboratory findings

At 5 years 8 months: 17-OHP 18 ng/mL (0.03-0.9), DHEAS 2.76 μg/mL (<0.05-0.57), androstenedione 1.4 ng/mL (0.08-0.5), total testosterone 0.3 ng/ml (<0.03-0.1), LH <0.1 mIU/mL, FSH 2.6 mIU/mL; repeat 17-OHP 17 ng/mL and at 6 years 7 months 19 ng/mL; electrolytes, ACTH, cortisol, renin and aldosterone normal; AMH 0.28 ng/mL.

Management

Hydrocortisone 5 mg/m²/day from 6 years 4 months (poor adherence), with emphasis on regular medication.

Pathology

Not reported in the original.

Evidence level

See source

Clinical history

See source

External genital examination

See source

Puberty / Tanner

See source

Cite this resource

DSD Research Library | Congenital adrenal hyperplasia (CAH) · DSD-T102 | v1.4.0 | 2026-11-17 | https://dsdatlas.com/en/cases/DSD-T102?version=v1.4.0